These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 10964947

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Group III human metabotropic glutamate receptors 4, 7 and 8: molecular cloning, functional expression, and comparison of pharmacological properties in RGT cells.
    Wu S, Wright RA, Rockey PK, Burgett SG, Arnold JS, Rosteck PR, Johnson BG, Schoepp DD, Belagaje RM.
    Brain Res Mol Brain Res; 1998 Jan; 53(1-2):88-97. PubMed ID: 9473604
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death.
    Bruno V, Copani A, Battaglia G, Raffaele R, Shinozaki H, Nicoletti F.
    Eur J Pharmacol; 1994 Apr 11; 256(1):109-12. PubMed ID: 7517889
    [Abstract] [Full Text] [Related]

  • 27. (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
    Thomsen C, Bruno V, Nicoletti F, Marinozzi M, Pellicciari R.
    Mol Pharmacol; 1996 Jul 11; 50(1):6-9. PubMed ID: 8700119
    [Abstract] [Full Text] [Related]

  • 28. Cellular mechanisms of protection by metabotropic glutamate receptors during anoxia and nitric oxide toxicity.
    Maiese K, Swiriduk M, TenBroeke M.
    J Neurochem; 1996 Jun 11; 66(6):2419-28. PubMed ID: 8632165
    [Abstract] [Full Text] [Related]

  • 29. Changes of mGluR4 and the effects of its specific agonist L-AP4 in a rodent model of diffuse brain injury.
    Zhou F, Hongmin B, Xiang Z, Enyu L.
    J Clin Neurosci; 2003 Nov 11; 10(6):684-8. PubMed ID: 14592619
    [Abstract] [Full Text] [Related]

  • 30. Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective.
    Bruno V, Ksiazek I, Battaglia G, Lukic S, Leonhardt T, Sauer D, Gasparini F, Kuhn R, Nicoletti F, Flor PJ.
    Neuropharmacology; 2000 Sep 11; 39(12):2223-30. PubMed ID: 10974306
    [Abstract] [Full Text] [Related]

  • 31. Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA-induced excitotoxicity in rat hippocampal slices.
    Pizzi M, Consolandi O, Memo M, Spano PF.
    Eur J Neurosci; 1996 Jul 11; 8(7):1516-21. PubMed ID: 8758959
    [Abstract] [Full Text] [Related]

  • 32. Neuroprotection by metabotropic glutamate receptor agonists on kainate-induced degeneration of motor neurons in spinal cord slices from adult rat.
    Pizzi M, Benarese M, Boroni F, Goffi F, Valerio A, Spano PF.
    Neuropharmacology; 2000 Mar 03; 39(5):903-10. PubMed ID: 10699456
    [Abstract] [Full Text] [Related]

  • 33. Mechanisms involved in the metabotropic glutamate receptor-enhancement of NMDA-mediated motoneurone responses in frog spinal cord.
    Holohean AM, Hackman JC, Davidoff RA.
    Br J Pharmacol; 1999 Jan 03; 126(1):333-41. PubMed ID: 10051153
    [Abstract] [Full Text] [Related]

  • 34. Activation of presynaptic group III metabotropic receptors enhances glutamate release in rat entorhinal cortex.
    Evans DI, Jones RS, Woodhall G.
    J Neurophysiol; 2000 May 03; 83(5):2519-25. PubMed ID: 10805653
    [Abstract] [Full Text] [Related]

  • 35. Molecular basis for the differential agonist affinities of group III metabotropic glutamate receptors.
    Rosemond E, Wang M, Yao Y, Storjohann L, Stormann T, Johnson EC, Hampson DR.
    Mol Pharmacol; 2004 Oct 03; 66(4):834-42. PubMed ID: 15231870
    [Abstract] [Full Text] [Related]

  • 36. Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death.
    Battaglia G, Bruno V, Ngomba RT, Di Grezia R, Copani A, Nicoletti F.
    Eur J Pharmacol; 1998 Sep 04; 356(2-3):271-4. PubMed ID: 9774259
    [Abstract] [Full Text] [Related]

  • 37. Influence of metabotropic glutamate receptor agonists on the inhibitory effects of adenosine A1 receptor activation in the rat hippocampus.
    de Mendonça A, Ribeiro JA.
    Br J Pharmacol; 1997 Aug 04; 121(8):1541-8. PubMed ID: 9283686
    [Abstract] [Full Text] [Related]

  • 38. Neuroprotection against hypoxic/hypoglycaemic injury after the insult by the group III metabotropic glutamate receptor agonist (R, S)-4-phosphonophenylglycine.
    Sabelhaus CF, Schröder UH, Breder J, Henrich-Noack P, Reymann KG.
    Br J Pharmacol; 2000 Oct 04; 131(4):655-8. PubMed ID: 11030711
    [Abstract] [Full Text] [Related]

  • 39. Anticonvulsant activity of a mGlu(4alpha) receptor selective agonist, (1S,3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid.
    Chapman AG, Talebi A, Yip PK, Meldrum BS.
    Eur J Pharmacol; 2001 Jul 20; 424(2):107-13. PubMed ID: 11476756
    [Abstract] [Full Text] [Related]

  • 40. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism.
    O'Leary DM, Movsesyan V, Vicini S, Faden AI.
    Br J Pharmacol; 2000 Dec 20; 131(7):1429-37. PubMed ID: 11090117
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.